Bussiness Ideas

Early detection plays a critical role in reducing mortality in diseases such as cancer. Many current diagnostic methods detect disease only after symptoms appear or when the disease has already progressed. There is a growing need for sensitive, minimally invasive tools that can identify disease at much earlier stages. Our company is developing a miRNA-panel-based machine learning model designed to early diagnosis of cancer and. MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate gene expression and circulate in body fluids such as blood. Changes in miRNA expression patterns often occur during the early stages of disease, making them promising biomarkers for early detection. The key component of our product is a curated panel of disease-associated miRNAs integrated with a machine learning model capable of analyzing complex expression patterns. By training the model on validated datasets, the platform can recognize molecular signatures linked to the early onset of cancer and cardiovascular conditions. This approach combines molecular diagnostics with advanced data analytics to generate risk predictions that support clinical decision-making. The technology aims to improve diagnostic accuracy, enable earlier interventions, and ultimately contribute to more effective preventive and personalized treatment strategies in healthcare systems globally today.

Startup Teams

• 1 Garima Jain (Founder)
• 2 Prakash Chandra Jain (Director)

Incubation Details

• Incubator Name
  BioNEST-BHU
• Incubator Host Institution
  Banaras Hindu University
• State
  Uttar Pradesh
• City
  Varanasi